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background: Torsade de pointes (or TdP) is a rare, life-threatening ventricular arrhythmia which can degenerate into ventricular fibrillation. QT 
prolongation has been associated with an increased risk for developing TdP. In a meta-analysis of 93 articles with a reported 332 cases of TdP, 
women made up 70% of the reported cases. The higher rate of TdP in women could be attributed to a longer QT interval in women or a higher 
sensitivity to QT-prolonging drugs. At present, however, the reason for the higher TdP rate in women is unknown. The aim of this project is to develop a 
quantitative risk model that relates the risk for TdP with QT prolongation, female gender and other risk factors.
methods: To better understand the relationship between TdP and different risk factors we first obtained a total of 42 studies from four 
antiarrhythmic drug development programs. Data from each study included: demographics, medical history, ECG measurements, drug treatment 
information, concomitant medication and if and when subjects developed a TdP event. The database included a total sample of 22643 (33% 
females), including 88 cases of TdP. Using this database we developed a logistic regression model, using penalized likelihood to account for the low 
event rate.
results: The logistic regression model showed that for every 10 ms of heart rate corrected QT prolongation (using Fridericia’s correction), the 
risk of TdP increased by 1.5% (p<0.0001) after adjusting for confounding factors. Similarly, the adjusted risk for TdP was 48.8% higher for females 
compared to males (p=0.0002).
conclusion: We have shown that after adjusting for potential confounders, QT prolongation and gender are still significant predictors of TdP. One 
potential limitation of this finding is the low event rate, but this was accounted for by using penalized likelihood. The main implication of this work 
is that increased risk for TdP in females might not be explained by medical history or QT prolongation, which can be thought of a surrogate for drug 
exposure levels, but perhaps an increased susceptibility to TdP.
